Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗
Elena Butz, Inga Steinbrenner, Ulla T. Schultheiss, Charlotte Behning et autres
de, us (code pays fourni par la source)